NCT01443377View on ClinicalTrials.gov

Neoadjuvant Radiochemotherapy Combined With Panitumumab in Locally Advanced KRAS Wild-type Rectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2013

Conditions
Rectal Cancer
Interventions
BIOLOGICAL

Panitumumab

Intravenous (IV), Panitumumab 6 mg/kg BW q2w d1-d57 (5 times total); begin on day 1 (run-in-phase) and subsequent application on days 15, 29 43 and 57.

Trial Locations (2)

60488

Krankenhaus Nord West, Radioonkologische Klinik, Frankfurt am Main

69120

National Center for Tumor Disease (NCT), Heidelberg

All Listed Sponsors
lead

National Center for Tumor Diseases, Heidelberg

OTHER

NCT01443377 - Neoadjuvant Radiochemotherapy Combined With Panitumumab in Locally Advanced KRAS Wild-type Rectal Cancer | Biotech Hunter | Biotech Hunter